List Trials for Newly Diagnosed Bladder Cancer

Bladder Cancer


Sirolimus + Cisplatin/Gemcitabine for Bladder Cancer (8027)
A Phase 1-2 Study of Rapamycin (Sirolimus) and Cisplatin/Gemcitabine for Treatment of Patients With Bladder Cancer

Investigator: Bruce Montgomery, MD;   Conditions: Bladder Cancer;    Status: Recruiting;   Study ID: NCT01938573

BCG plus ALT-803 for Non-muscle Invasive Bladder Cancer
A Study of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 in Patients With BCG-naive Non-Muscle Invasive Bladder Cancer

Investigator: Heather H. Cheng, MD, PhD;   Conditions: Non-muscle Invasive Bladder Cancer;    Status: Pending;   Study ID: NCT02138734

Gabapentin for Bladder Cancer Patients Undergoing Surgery (9274)
Randomized placebo control trial of perioperative gabapentin to reduce total analgesic requirements in patients undergoing radical cystectomy

Investigator: Jonathan Wright;   Conditions: Bladder Cancer;    Status: Recruiting;   Study ID: NCT02355886

Postoperative Radiation Therapy for Bladder Cancer (NRG-GU001)
Randomized Phase II Trial of Postoperative Adjuvant IMRT Following Cystectomy for pT3/T4 Urothelial Bladder Cancer

Investigator: Jing Zeng, MD;   Conditions: Bladder Cancer; Solid Tumors;    Status: Recruiting;   Study ID: NCT02316548

Pembrolizumab (MK-3475)for Metastatic Urothelial Cancer (201500280)
A Phase II Clinical Trial of Pembrolizumab (MK-3475) in Subjects with Advanced/Unresectable or Metastatic Urothelial Cancer

Investigator: Evan Yu, MD;   Conditions: Bladder Cancer; Urothelial Cancer;    Status: Recruiting;   Study ID: NCT02335424